most reputable telehealth services for semaglutide prescriptions Compounded Weight Loss Reviews: What To Know TMates Review 2026: GLP-1 Telehealth,

This new complaint, along with a few others, centers on vision loss, alleging that Novo Nordisk failed to adequately warn users about the risk of developing non-arteritic anterior ischemic optic neuropathy (NAION), a rare condition characterized by reduced blood flow to the optic nerve

Due to serious side effects many cannot be taken long-term

Increasing awareness about weight management and metabolic health is expanding patient adoption

doi: 10.1038/oby.2009.510CrossRefGoogle ScholarPubMed Moaddel, R., Shardell, M., Khadeer, M., Lovett, J., Kadriu, B., Ravichandran, S., Zarate, C

Semaglutide is a class of medication called glucagon-like peptide 1 (GLP-1) approved for the treatment of obesity or overweight adults with at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol